title: Malignant mixed epithelial/mesenchymal neoplasms of the lung.
abstract: The existence of biphasic neoplasms occurring primarily in the lung is a well-known albeit rare event. The spectrum of malignant tumors displaying a mixed epithelial/mesenchymal growth pattern is rather narrow when these tumors occur primarily in the lung. The two most often encountered neoplasms showing features of epithelial and mesenchymal differentiation are carcinosarcomas and pulmonary blastomas. Tumors with analogous features are of ubiquitous distribution in the human body and have been described in numerous other organs, including the gastrointestinal tract, the genitourinary tract, and the endocrine system. Although the histopathologic features of these tumors may seem simple in most cases, there appear to be numerous pitfalls in their diagnosis; gray areas still remain in the characterization of these tumors, because a certain degree of overlap may be encountered with these two conditions. Such problems are understandable because the incidence of these tumors in the general population is very rare. Therefore, one is expected to find divergent points of view regarding these neoplasms. It is of importance, however, to unify criteria not only for diagnostic purposes, but also to determine the prevalence and behavior of these neoplasms, because such information may provide a rationale for adjustment and improvement in the treatment and diagnosis of these unusual neoplasms. We will review past and current concepts regarding these unusual tumors, as well as their more salient histopathologic features.
authors.affiliation: Arkadi M. Rywlin Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
authors.forename: M
authors.initials: M
authors.lastname: Berho
authors.forename: C A
authors.initials: CA
authors.lastname: Moran
authors.forename: S
authors.initials: S
authors.lastname: Suster
mesh_terms: D017677:Age Distribution; D002296:Carcinosarcoma / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000737:chemistry / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy; D008297:Male; D011379:Prognosis; D018202:Pulmonary Blastoma / Q000175:diagnosis / Q000473:pathology* / Q000628:therapy